Summary
Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vectors, and protein expression. It also offers CloneSmart, BigEasy Linear, DNATerminator End Repair Kit, CloneDirect Rapid Ligation Kit, UltraClone DNA Ligation and Transformation Kits, Gel-Ready DNA Ladders, NxGen Exonuclease I, NxGen Lambda Exonuclease and Pyrophosphatase, among others. The company offers next gen sequencing services such as DNA-specific sequencing services and RNA-specific sequencing services. Lucigen is headquartered in Middleton, Wisconsin, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
Reasons to Buy
Note: Some sections may be missing if data is unavailable for the company
Lucigen Corp (Lucigen), a subsidiary of LGC Ltd, is a medical device company that discovers, manufactures, and commercializes molecular biology product. The company’s products comprise competent cells, nextgen seq, enzymes, cloning systems, PCR and amplification, cloning test kits and vectors, and protein expression. It also offers CloneSmart, BigEasy Linear, DNATerminator End Repair Kit, CloneDirect Rapid Ligation Kit, UltraClone DNA Ligation and Transformation Kits, Gel-Ready DNA Ladders, NxGen Exonuclease I, NxGen Lambda Exonuclease and Pyrophosphatase, among others. The company offers next gen sequencing services such as DNA-specific sequencing services and RNA-specific sequencing services. Lucigen is headquartered in Middleton, Wisconsin, the US.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Lucigen Corp
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Lucigen Corp Company Overview
Lucigen Corp – Pipeline Analysis Overview
Lucigen Corp Pipeline Products Overview
Lucigen Corp - Locations And Subsidiaries
Recent Developments
Appendix
List of Tables
List of Figures
Samples
LOADING...
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Lucerna Inc
- Cellogenetics Inc
- H.R. Simon and Company Inc
- Empire Genomics LLC
